Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

Abstract

loading...

About

This paper, published in 1950, received 602 indexed citations. Written by Hans-Peter Hammes, Xueliang Du, Diane Edelstein, Tetsuya Taguchi, Takeshi Matsumura, Qida Ju, Jihong Lin, Angelika Bierhaus, Peter P. Nawroth and D Hannak covering the research area of Neurology, Pathology and Forensic Medicine and Biochemistry. It is primarily cited by scholars working on Clinical Biochemistry (252 citations), Endocrinology, Diabetes and Metabolism (187 citations) and Neurology (156 citations). Published in Nature Medicine.

In The Last Decade

doi.org/10.1038/nm834 →

Countries where authors are citing Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

Since Specialization
Citations

This map shows the geographic impact of Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy more than expected).

Fields of papers citing Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm834.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026